During the past decade, Philadelphia Institute of Dermatology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Philadelphia Institute of Dermatology" are "Actinic Keratosis" (1 trials) and "Genital Warts" (1 trials). Many other conditions were trialed in "Philadelphia Institute of Dermatology" in a lesser frequency.

Most popular intervention types in "Philadelphia Institute of Dermatology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "3.75% imiquimod cream" (1 trials), "Imiquimod" (1 trials), "PEP005 Topical Gel" (1 trials), "Vehicle gel" (1 trials) and "placebo cream" (1 trials). Other intervention names were less common.

The vast majority of trials in "Philadelphia Institute of Dermatology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Philadelphia Institute of Dermatology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Philadelphia Institute of Dermatology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Philadelphia Institute of Dermatology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Philadelphia Institute of Dermatology has several departments that took part in Clinical trials: "Philadelphia Institute of Dermatology" - 13 trials